These data may help to consider developing pharmacological inhibitors of PKR either alone or in combination with IFN or direct antiviral agents as a reliable therapeutic approach to limit stress-induced damages or limit some viral infections. The gene discussed is EIF2AK2; the disease is viral infectious disease.